Senior Principal Scientist, Clinical Pharmacology @ (October 2020 - June 2023)
Scientist, Clinical Pharmacology @ (July 2017 - October 2020)
Clinical Pharmacologist II @ (January 2017 - June 2017)
Clinical Pharmacologist I @ (April 2015 - January 2017)
Postdoctoral Fellow (Clinical PK and PD and Pharmacometrics) @ Biomedical Simulations Resource, University of Southern California (April 2014 - March 2015)
Ethnopharmacology Scientist @ (January 2014 - April 2014)
Research Assistant in Herb-Drug Interactions @ (January 2011 - April 2014)
PhD Candidate @ (February 2010 - November 2013)
Associate Pharmacokineticist @ (March 2009 - December 2009)
Graduate Hospital Pharmacist @ Central Coast Local Health District (January 2008 - January 2009)
Michael Dolton Education
University of Sydney
Doctor of Philosophy (PhD) (Clinical Pharmacology / Pharmacy)
2010-2013
University of Sydney
Bachelor of Pharmacy (B.Pharm.) (Pharmacy)
2004-2007
Michael Dolton Skills
Animal Models
Antifungal Medicines
Clinical Pharmacology
Clinical Pharmacy
Clinical Research
Dose Individualisation
Drug Delivery
Drug Development
Exposure-response relationships
Herb-drug Interactions
In Vitro
Life Sciences
Medical Writing
Neuroscience
PK/PD
Pharmacodynamics
Pharmacokinetics
Pharmacology
Pharmacometrics
Population pharmacokinetic modeling
Therapeutic Drug Monitoring
Herb Drug Interactions
Exposure Response Relationships
Michael Dolton Summary
Michael Dolton, based in California, United States, is currently a Distinguished Scientist, Clinical Pharmacology at Genentech. Michael Dolton brings experience from previous roles at Genentech and Gilead Sciences. Michael Dolton holds a 2010 - 2013 Doctor of Philosophy (PhD) in Clinical Pharmacology / Pharmacy @ University of Sydney. With a robust skill set that includes Animal Models, Antifungal Medicines, Clinical Pharmacology, Clinical Pharmacy, Clinical Research and more. Michael Dolton has 2 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Michael Dolton?
Find contact details for 700 million professionals.